Purple Biotech Ltd
NASDAQ:PPBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Purple Biotech Ltd
NASDAQ:PPBT
|
IL |
|
Amuse Inc
TSE:4301
|
JP |
|
M
|
Mediclin AG
F:MED
|
DE |
|
Synlab AG
XETRA:SYAB
|
DE |
|
I
|
IG Group Holdings PLC
OTC:IGGRF
|
UK |
|
ZTO Express (Cayman) Inc
HKEX:2057
|
CN |
Purple Biotech Ltd
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
